XML 9 R4.htm IDEA: XBRL DOCUMENT  v2.3.0.11
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
3 Months Ended 6 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Jun. 30, 2011
Jun. 30, 2010
REVENUES:        
Operating Revenues – equipment sales and related services $ 285,097 $ 274,343 $ 580,927 $ 590,728
Operating Revenues – cryobanking and related services 73,042 93,989 154,681 173,876
Total Revenues 358,139 368,332 735,608 764,604
Cost of equipment sales and related services 155,056 156,329 309,287 342,290
Cost of cryobanking and related services 5,671 9,082 16,894 14,898
Total Cost of Sales 160,727 165,411 326,181 357,188
Gross Profit 197,412 202,921 409,427 407,416
OPERATING EXPENSES:        
Research and development-equipment sales and related services 616,480 687,115 1,262,307 1,523,978
Research and development-cryobanking and related services 53,303 47,454 97,066 102,556
Total Research and Development Expenses 669,783 734,569 1,359,373 1,626,534
Selling, general, and administrative- equipment sales and related services 726,025 817,469 2,263,902 1,299,213
Selling, general, and administrative- cryobanking and related services 145,401 155,953 305,886 328,895
Total Selling, General & Administrative Expenses 871,426 973,422 2,569,788 1,628,108
Total Operating Expenses 1,541,209 1,707,991 3,929,161 3,254,642
Loss from Operations (1,343,797) (1,505,070) (3,519,734) (2,847,226)
Dividend income-investment portfolio 499,887 518,858 1,073,553 1,087,266
Realized gains on sale of securities and options, net 2,279,674 1,489,665 6,024,047 7,566,047
Mark to market adjustments on short sales of options (1,687,134) (318,123) (6,155,563) (5,090,887)
Other revenues 3,094 3,042 6,188 6,083
Interest expense (81,260) (8,919) (111,908) (15,183)
Administrative expense relating to portfolio investments (37,315) (31,043) (69,709) (66,017)
Total Other Income 976,946 1,653,480 766,608 3,487,309
(Loss) Income before Income Taxes (366,851) 148,410 (2,753,126) 640,083
Income Tax (Benefit) (182,331) (39,946) (1,242,344) 544,146
Net (Loss) Income (184,520) 188,356 (1,510,782) 95,937
Net (Loss) Income (184,520) 188,356 (1,510,782) 95,937
Unrealized Gain (Loss) on Securities Held for Sale, Net of Deferred Income Taxes 323,655 (3,268,794) 751,535 (4,121,736)
Comprehensive Income (Loss) $ 139,135 $ (3,080,438) $ (759,247) $ (4,025,799)
Weighted average number of shares outstanding – basic and diluted (in Shares) 4,225,349 4,242,285 4,225,743 4,244,785
Net (Loss) Income per common equivalent share – basic and diluted (in Dollars per share) $ (0.04) $ 0.04 $ (0.36) $ 0.02
Dividends paid per common share (in Dollars per share) $ 0.15 $ 0.10 $ 0.15 $ 0.10